Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;119(4):737-46.
doi: 10.1172/JCI37563. Epub 2009 Apr 1.

Children with obsessive-compulsive disorder: are they just "little adults"?

Affiliations
Review

Children with obsessive-compulsive disorder: are they just "little adults"?

Simran K Kalra et al. J Clin Invest. 2009 Apr.

Abstract

Childhood-onset obsessive-compulsive disorder (OCD) affects 1%-2% of children and adolescents. It is characterized by recurrent obsessions and compulsions that create distress and interfere with daily life. The symptoms reported by children are similar to those seen among individuals who develop OCD in adulthood, and the two groups of patients are treated with similar symptom-relieving behavior therapies and medications. However, there are differences in sex ratios, patterns of comorbidity, and the results of neuroimaging studies that might be important. Here we review the diagnosis and treatment of childhood-onset OCD in light of pediatric and adult studies. We also discuss current knowledge of the pathophysiology of the disorder. Despite advances in this area, further research is needed to understand better the etiopathogenesis of the disorder and to develop new, more effective therapeutic options.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Model for the cortico-striato-thalamo-cortical circuit dysfunction in individuals with OCD.
This model outlines the hypothesis that the cortico-striato-thalamo-cortical circuit is dysfunctional in individuals with OCD. Increased glutamatergic signals from the frontal cortex are hypothesized to increase excitation in the striatum, which increases inhibitory GABA signals to the GPi and SNr. (A) One possibility is that this then decreases the inhibitory output via GABA from the GPi and SNr to the thalamus, resulting in thalamic excitatory glutamatergic output to the frontal cortex. This positive feedback loop leads to repetitive thoughts (obsessions) and behaviors (compulsions). An indirect external loop composed of the GPe and subthalamic nucleus (STN) is postulated to contribute to a steady state of excitation/inhibition in this model. (B) A second possibility is that there is an unknown dysfunction at the striatum and GPe. Decreased inhibition on the GPe leads to increased inhibition of the STN, which decreases its excitation of the GPi/SNr. The GPi/SNr then decreases its inhibitory output on the thalamus, resulting in excitatory output to the frontal cortex (adapted from ref. 67).
Figure 2
Figure 2. The cortico-striato-thalamo-cortical circuit in a healthy individual.
In the normally functioning cortico-striato-thalamo-cortical circuit, glutamatergic signals from the frontal cortex lead to excitation in the striatum, which increases inhibitory GABA signals to the GPi and the SNr. This then decreases the inhibitory output via GABA from the GPi and SNr to the thalamus, resulting in thalamic excitatory glutamatergic output to the frontal cortex. This is a positive feedback loop. An indirect external loop composed of the GPe and subthalamic nucleus (STN) is postulated to contribute to a steady state of excitation/inhibition. The striatum inhibits the GPe, which decreases its inhibition on the STN. The STN is then free to excite the GPi/SNr and therefore inhibit the thalamus (adapted from ref. 67).
Figure 3
Figure 3. Serial T1-weighted brain MRIs of a 14-year-old male patient with severe worsening of OCD symptoms after an infection with GABHS.
MRI was performed before and after treatment with plasma exchange. Note the decreased caudate size after treatment (outlined with dotted and solid lines). This provides further support for basal ganglia–mediated dysfunction in OCD and the potential for immunological treatments for PANDAS. Adapted with permission from Oxford University Press (124).

References

    1. American Psychiatric Association and American Psychiatric Association Task Force on DSM-IV. 2000.Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association. Washington, DC, USA. 943 pp.
    1. Leckman J.F., et al. Symptoms of obsessive-compulsive disorder. Am. J. Psychiatry. 1997;154:911–917. - PubMed
    1. Goodman W.K., et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch. Gen. Psychiatry. 1989;46:1006–1011. - PubMed
    1. Poyurovsky M., Faragian S., Shabeta A., Kosov A. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 2008;159:133–139. doi: 10.1016/j.psychres.2007.06.010. - DOI - PubMed
    1. Storch E.A., et al. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr. Psychiatry. 2008;49:35–42. doi: 10.1016/j.comppsych.2007.06.009. - DOI - PubMed